Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
about
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.The Renaissance of platinum-based chemotherapy for metastatic breast cancer.Platinum-based compounds for the treatment of metastatic breast cancer.Polyelectrolyte multilayer nanoshells with hydrophobic nanodomains for delivery of Paclitaxel.
P2860
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@ast
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@en
type
label
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@ast
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@en
prefLabel
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@ast
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@en
P2093
P2860
P356
P1476
Weekly paclitaxel-cisplatin ad ...... east cancer. A phase II study.
@en
P2093
Barbarulo D
Budillon A
Caponigro F
Caratení G
Casaretti R
P2860
P2888
P356
10.1023/A:1005945218155
P407
P577
1998-05-01T00:00:00Z
P6179
1000296345